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in the management of DRESS Syndrome. Herewith presenting a case of an adolescent girl with rashes 
and systemic symptoms, the cause of which, on obtaining a detailed history and step wise investigations 
was diagnosed as DRESS Syndrome. 
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Abstract
Drug Rash with Eosinophilia and Systemic 
Symptoms (DRESS) Syndrome is a rare, 
life-threatening hypersensitivity reaction 
that causes skin exfoliation, hematological 
abnormalities, lymphadenopathy, and 
extensive internal organ involvement. 
Characterized by a long latency period, this 
unusual side effect of aromatic anti-epileptic 
drugs, as well as many common drugs cause 
a mortality rate of up to 10% if left untreated. 
In the absence of a well-established therapy, 
primary and secondary prevention have a key 
role in the management of DRESS Syndrome. 
Herewith presenting a case of an adolescent 
girl with rashes and systemic symptoms, the 
cause of which, on obtaining a detailed history 
and step wise investigations was diagnosed as 
DRESS Syndrome.
Introduction 
A skin rash with hematological abnormalities 
in an adolescent girl poses several differential 
diagnoses. One under-recognized etiology 
of skin changes with internal organ 
involvement in this age group is Drug Rash 
with Eosinophilia with Systemic Symptoms 
(DRESS Syndrome). DRESS Syndrome is 
diagnosed by a process of elimination, ruling 
out the more common conditions including 
Systemic Lupus Erythematosus, Kawasaki, 
and Steven Johnson Syndrome in addition to 
confirming the diagnosis using the RegiSCAR 
criteria.1 There is paucity of data on DRESS 
syndrome and thus many go undiagnosed or 
are improperly managed. An early diagnosis 
of DRESS Syndrome is key to successful 
treatment and reduction in mortality. Herewith 
presenting a case of DRESS syndrome with 
classic clinical and biochemical features 
whom had quick recovery following 
withdrawal of the suspected drug along with 
short course of steroid therapy. Consent 
was obtained from the patient to use her 
information and images for educational 
purposes. 
Case 
A 17 year old, developmentally normal 
adolescent, presented with acute onset 
abdominal pain, fever and vomiting. She soon 
developed maculopapular rashes beginning 
with face (Figure 1) and extremities (Figure 
2) that later became generalized with itching. 
There was no similar episode in the past 
and no contributory family history. Positive 
examination findings included non-tender 
significant cervical lymphadenopathy, 
non-palpable maculopapular rashes over 
the extensor aspects of the limbs and face 
with exfoliation of skin over the extremities, 
bilateral pitting and pedal edema (Figure 3). 
Abdominal examination revealed moderate 
hepatomegaly and stable vital signs.
Baseline investigations were done 
that revealed a total hemoglobin count 
of 9.9mg/dl, total white cell count of 
15,400cu/mm with eosinophilia of 27% 
and a normal platelet count. Her absolute 
eosinophil count was 4,000 cu/mm and her 
Erythrocyte Sedimentation Rate (ESR) was 
moderately elevated at 32 mm/hr. In view of 
hepatomegaly, liver function tests were done 
that showed an elevated SGOT of 90 U/L, 
SGPT of 86 U/L with normal bilirubin and 
alkaline phosphatase levels. She had trace 
proteins in her urine. Her urine spot protein 
creatinine ratio was less than 2, normal 
Complement 3 (C3), and Complement 4 (C4) 
levels with Antinuclear Antibodies (ANA) 
negative. An echocardiogram demonstrated no 
pertinent findings. On probing her past history, 
she was recently evaluated by a private 
practitioner and diagnosed with probable 
complex partial seizures for which she was 
started on carbamazepine at the dose of 2mg/
kg 3 times a day over the last 4 weeks. As 
she had skin involvement with eosinophilia 
and hepatic involvement, Drug Reaction 
with Eosinophilia and Systemic Symptoms 
(DRESS) Syndrome was suspected. The 
offending drug was immediately stopped 
and replaced with Levetiracetam. A skin 
biopsy was performed which demonstrated 
eosinophilia along with atypical lymphocytes, 
confirming the diagnosis of DRESS 
Syndrome. As she had a prolonged course 
of illness, she was also treated with a short 
course steroid therapy. Within a week of 
therapy, she experienced complete clinical and 
biochemical remission.
Discussion 
With the initial presenting complaints 
of acute onset fever and rash, a simple 
viral exanthematous illness was our first 
Figure 1. Cutaneous maculopapular eruption 
with exfoliate dermatitis and facial edema with 
cheilitis noted.
Figure 2. Maculopapular rash seen affecting the 
palms.
Figure 3. Maculopapular rash with desqua-
mation and pedal edema affecting the lower 
extremities.
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outpatient diagnosis. But the prolonged 
course of illness that was not resolving with 
medical management and the characteristic 
maculopapular rash with itching and 
exfoliation urged us to look for an alternative 
diagnosis.
In the general population, the first course 
of action for an adolescent girl presenting 
with rash, elevated ESR, and trace protein 
in urine is to rule out Systemic Lupus 
Erythematosus (SLE). A rash in SLE is more 
often a malar or butterfly type which varies 
from an erythematous blush to thickened 
epidermis to scaly patches which may be 
photosensitive and extend to all sun-exposed 
areas.2 Our child did not fit into the classical 
Revised Classification Criteria for Systemic 
Lupus Erythematosus clinically as well as 
biochemically because her ANA was negative- 
thus we probed further into evaluating this 
young girl.
On further examination, the presence 
of rash, edema of feet, and non-tender 
unilateral lymph node cervical enlargement, 
Kawasaki disease was considered. However, 
to diagnose Kawasaki disease, at least 4 of 
the principle clinical features, including the 
full epidermal peeling-periungual peeling, 
changes in extremities erythema of palms, 
soles, polymorphous exanthema, bilateral 
bulbar conjunctival injection without exudate 
erythema, lip cracking, and strawberry tongue 
are essential.3 But our patient had more of a 
monomorphous rash, with exfoliation only 
at the tips of digits (Figure 4) and therefore 
did not fit into the diagnostic criteria. We 
proceeded with an echocardiogram to rule 
out incomplete forms of Kawasaki disease 
as the child was in the adolescent age 
group with moderately elevated ESR. The 
echocardiogram was normal.
Due to recent anti-seizure medication and 
her clinical picture, the possibility of Steven 
Johnson Syndrome (SJS) was considered. SJS 
can occur 2 to 6 weeks following initiation 
of similar anticonvulsant medication and 
present with an eosinophilic blood picture.4 
However, the patient’s rash, beginning from 
face and extremities, and hepatic involvement 
combined with absence of mucosal 
involvement were uncharacteristic of SJS.
In conclusion, we narrowed our diagnosis to 
DRESS Syndrome due to the constellation of 
findings consisting of fever, rash following 
carbamazepine intake in the recent past 
requiring hospitalization, eosinophilia and 
hepatic involvement. In addition, the patient 
presented with findings that satisfied the 
RegiSCAR criteria for the diagnosis of 
DRESS Syndrome.1 A skin biopsy showing 
increased eosinophil count along with atypical 
lymphocytes reaffirmed our diagnosis. 
Furthermore, mere withdrawal of the 
offending drug and a short course of steroids 
led to a complete clinical and biochemical 
resolution.
Conclusion 
Diagnosis of DRESS Syndrome can be 
difficult due to the variable presentations 
of the syndrome and is often obtained only 
after exclusion of commoner causes. In 
addition, the long latency period following 
initiation or after stopping the medication 
creates difficulties in diagnosis. This report 
is of clinical significance due to paucity 
of data DRESS Syndrome as many cases 
go undiagnosed or result in an alternate 
diagnosis. This case was presented to 
highlight the fact that a clinical suspicion 
of the above is essential for appropriate 
management and prevention of mortality. 
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Figure 4. Monomorphous rash and with exfolia-
tion affecting the digits. 
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